Acquirer | Target | Price |
---|---|---|
Octopharma AG | License to Glycotope’s recombinant technology | $90.9 million |
Nassua Reinsurance Group | UAM's Traditional Insurance business | $63 million |
AmerisourceBergen Corp. | PharMEDium Healthcare Holdings | $2.58 billion |
Partners Pharmacy | Tech Pharmacy Services, Inc. | N/A |